Latest news

Filters
March 17, 2002

H3 Pharma Licenses in Phase II Product for Stomach Cancer and Acquires Stake in a Human mAb Discovery Company Specializing…

Read more
March 12, 2002

Swiss company Debio R.P. announces Agreement with Inhale subsidiary Shearwater Corporation

Read more
July 5, 2001

Swiss drug developer Debiopharm announces FDA approval of Trelstar TM LA for therapeutic use

Read more
June 7, 2001

New pharmaceutical development company in Quebec : The SGF and the Swiss Group Debio create H3 BioDé

Read more
May 19, 2001

Partenariat entre l’Ecole de Pharmacie Genève-Lausanne (EPGL) et Debiopharm Group™ – L’Université et l’Industrie allient leurs forces

Read more
April 14, 2001

Debiopharm and Aurigene sign agreement for the development and commercialisation of Debio 1142, a novel inhibitor of an undisclosed oncology…

Read more
February 13, 2001

Dyax Corp. and Debiopharm S.A. report initiation of phase II clinical trial with EPI-HNE-4 for cystic fibrosis

Read more
January 10, 2001

Swiss drug developer Debiopharm S.A. achieves another success in the development of molecules for theraeutic use

Read more